Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 834 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 511.80 USD | -0.96% | -0.43% | -7.78% | +20.82% | 11.82 B USD | ||
| 861 |  TECH Bio-Techne Corp - Common Stock | 72.36 USD | +0.06% | -0.03% | +0.98% | +27.26% | 11.33 B USD | ||
| 876 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 206.30 USD | -0.71% | -3.80% | -14.20% | +58.45% | 10.81 B USD | ||
| 886 |  CYTK Cytokinetics, Incorporated - Common Stock | 76.14 USD | -0.91% | +3.06% | -6.59% | +31.05% | 10.59 B USD | ||
| 898 |  SMMT Summit Therapeutics Inc. - Common Stock | 12.46 USD | -5.32% | +2.13% | -10.04% | -37.26% | 9.94 B USD | ||
| 899 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 365.98 USD | -2.65% | -3.34% | +12.51% | +658.98% | 10.22 B USD | ||
| 919 |  KRYS Krystal Biotech, Inc. - Common Stock | 344.62 USD | -0.57% | +3.76% | +1.63% | +84.16% | 10.20 B USD | ||
| 933 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.54 USD | -0.62% | +1.02% | +24.75% | +98.08% | 9.99 B USD | ||
| 936 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 151.51 USD | -1.82% | -2.06% | +11.31% | +101.66% | 9.80 B USD | ||
| 938 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 117.13 USD | -2.23% | -1.16% | +5.93% | +98.19% | 9.74 B USD | ||
| 940 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 60.33 USD | +0.99% | +6.63% | +6.59% | -16.35% | 10.03 B USD | ||
| 963 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 105.52 USD | -0.91% | +2.35% | +2.95% | +341.32% | 9.30 B USD | ||
| 969 |  PCVX Vaxcyte, Inc. - Common Stock | 61.46 USD | -1.85% | +3.87% | +12.21% | +45.30% | 9.15 B USD | ||
| 978 |  IMVT Immunovant, Inc. - Common Stock | 43.66 USD | -1.60% | +3.85% | +9.23% | +127.28% | 9.02 B USD | ||
| 987 |  ABVX Abivax SA - American Depositary Shares | 113.87 USD | -0.94% | -5.55% | -9.58% | +47.73% | 8.94 B USD | ||
| 993 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.78 USD | +0.11% | +0.09% | +1.17% | +106.28% | 8.99 B USD | ||
| 1034 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.76 USD | +0.01% | +0.16% | +0.36% | +151.46% | 8.38 B USD | ||
| 1039 |  TGTX TG Therapeutics, Inc. - Common Stock | 53.62 USD | -1.20% | +9.54% | -6.42% | +81.95% | 8.21 B USD | ||
| 1045 |  IBRX ImmunityBio, Inc. - Common Stock | 7.55 USD | -3.08% | -1.31% | +3.99% | +226.84% | 8.00 B USD | ||
| 1079 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 110.40 USD | +0.36% | -5.27% | +5.50% | +0.08% | 7.60 B USD |
Notícias Biotechnology Stocks
Deutsche Bank rebaixa argenx para neutro após valorização expressiva
Por que as ações da Monte Rosa Therapeutics estão caindo hoje?
Ações da Biomea Fusion disparam com conclusão de inscrições em estudo sobre diabetes
Ações da Monte Rosa caem com início de estudo de fase 2 contra câncer de próstata
Ação da Crinetics Pharmaceuticals atinge máxima histórica de US$ 84,80
H.C. Wainwright reitera recomendação para Biomea Fusion após conclusão de recrutamento em ensaio clínico
FDA prorroga revisão do deramiocel da Capricor para novembro de 2026
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
 ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
 OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |